Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11766411 Use of cannabinoids in the treatment of epilepsy

Overview Structured Data Issues Contributors Activity

Is a

Date Filed

July 29, 2022

Date of Patent

September 26, 2023

Patent Application Number

17816349

Patent Citations

US Patent 11357741 Use of cannabinoids in the treatment of epilepsy

US Patent 11207292 Cannabidiol preparations and its uses

US Patent 11311498 Use of cannabinoids in the treatment of epilepsy

US Patent 11400055 Use of cannabidiol in the treatment of epilepsy

US Patent 11406623 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

US Patent 11419829 Use of cannabidiol in combination with 5-HT2B receptor agonists or amphetamines in the treatment of epilepsy

US Patent 11426362 Oral cannabinoid formulations

US Patent 11446258 Use of cannabinoids in the treatment of epilepsy

US Patent 11590087 Cannabidiol-type cannabinoid compound

US Patent 8293786 Prodrugs of cannabidiol, compositions comprising prodrugs of cannabidiol and methods of using the same

•••

Patent Citations Received

US Patent 12102619 Methods of treating tuberous sclerosis complex with cannabidiol and everolimus

0

Patent Inventor Names

Stephen Wright

Geoffrey Guy

Orrin Devinsky

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Primary Examiner

Matthew P Coughlin

CPC Code

Find more entities like US Patent 11766411 Use of cannabinoids in the treatment of epilepsy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool